National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

This is VAERS ID 629126

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 4/14/2016

VAERS ID: 629126
VAERS Form:
Age:
Sex:Female
Location:Unknown
Vaccinated:2016-03-10
Onset:2016-03-10
Submitted:2016-03-24
Entered:2016-03-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS PP148901A / - LA / UN
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / - UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site pain, Musculoskeletal pain, Paraesthesia

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016038974

Write-up: This case was reported by a physician via call center representative and described the occurrence of shoulder pain in a female patient who received BEXSERO (batch number PP-148901A, expiry date 30th September 2016). Concomitant products included MENACTRA. On 10th March 2016, the patient received BEXSERO .5 ml. On 10th March 2016, less than a day after receiving BEXSERO, the patient experienced shoulder pain and injection site pain. In March 2016, the patient experienced tingling of extremity. On an unknown date, the outcome of the shoulder pain and injection site pain were not recovered/not resolved and the outcome of the tingling of extremity was unknown. It was unknown if the reporter considered the shoulder pain, injection site pain and tingling of extremity to be related to BEXSERO. Additional details were as follows: The patient experienced deep left shoulder pain, painful to touch at injection site and tingling down left arm (less than a week after vaccination). The reporter was unable to provide patient''s date of birth.


Changed on 9/14/2017

VAERS ID: 629126 Before After
VAERS Form:(blank) 1
Age:
Sex:Female
Location:Unknown
Vaccinated:2016-03-10
Onset:2016-03-10
Submitted:2016-03-24
Entered:2016-03-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS PP148901A / - UNK LA / UN
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / - UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site pain, Musculoskeletal pain, Paraesthesia

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016038974

Write-up: This case was reported by a physician via call center representative and described the occurrence of shoulder pain in a female patient who received BEXSERO (batch number PP-148901A, expiry date 30th September 2016). Concomitant products included MENACTRA. On 10th March 2016, the patient received BEXSERO .5 ml. On 10th March 2016, less than a day after receiving BEXSERO, the patient experienced shoulder pain and injection site pain. In March 2016, the patient experienced tingling of extremity. On an unknown date, the outcome of the shoulder pain and injection site pain were not recovered/not resolved and the outcome of the tingling of extremity was unknown. It was unknown if the reporter considered the shoulder pain, injection site pain and tingling of extremity to be related to BEXSERO. Additional details were as follows: The patient experienced deep left shoulder pain, painful to touch at injection site and tingling down left arm (less than a week after vaccination). The reporter was unable to provide patient''s date of birth.


Changed on 2/14/2018

VAERS ID: 629126 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:2016-03-10
Onset:2016-03-10
Submitted:2016-03-24
Entered:2016-03-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS PP148901A / UNK LA / UN
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site pain, Musculoskeletal pain, Paraesthesia

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016038974

Write-up: This case was reported by a physician via call center representative and described the occurrence of shoulder pain in a female patient who received BEXSERO (batch number PP-148901A, expiry date 30th September 2016). Concomitant products included MENACTRA. On 10th March 2016, the patient received BEXSERO .5 ml. On 10th March 2016, less than a day after receiving BEXSERO, the patient experienced shoulder pain and injection site pain. In March 2016, the patient experienced tingling of extremity. On an unknown date, the outcome of the shoulder pain and injection site pain were not recovered/not resolved and the outcome of the tingling of extremity was unknown. It was unknown if the reporter considered the shoulder pain, injection site pain and tingling of extremity to be related to BEXSERO. Additional details were as follows: The patient experienced deep left shoulder pain, painful to touch at injection site and tingling down left arm (less than a week after vaccination). The reporter was unable to provide patient''s date of birth.


Changed on 6/14/2018

VAERS ID: 629126 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:2016-03-10
Onset:2016-03-10
Submitted:2016-03-24
Entered:2016-03-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS PP148901A / UNK LA / UN
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site pain, Musculoskeletal pain, Paraesthesia

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016038974

Write-up: This case was reported by a physician via call center representative and described the occurrence of shoulder pain in a female patient who received BEXSERO (batch number PP-148901A, expiry date 30th September 2016). Concomitant products included MENACTRA. On 10th March 2016, the patient received BEXSERO .5 ml. On 10th March 2016, less than a day after receiving BEXSERO, the patient experienced shoulder pain and injection site pain. In March 2016, the patient experienced tingling of extremity. On an unknown date, the outcome of the shoulder pain and injection site pain were not recovered/not resolved and the outcome of the tingling of extremity was unknown. It was unknown if the reporter considered the shoulder pain, injection site pain and tingling of extremity to be related to BEXSERO. Additional details were as follows: The patient experienced deep left shoulder pain, painful to touch at injection site and tingling down left arm (less than a week after vaccination). The reporter was unable to provide patient''s date of birth.


Changed on 8/14/2018

VAERS ID: 629126 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:2016-03-10
Onset:2016-03-10
Submitted:2016-03-24
Entered:2016-03-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS PP148901A / UNK LA / UN
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site pain, Musculoskeletal pain, Paraesthesia

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016038974

Write-up: This case was reported by a physician via call center representative and described the occurrence of shoulder pain in a female patient who received BEXSERO (batch number PP-148901A, expiry date 30th September 2016). Concomitant products included MENACTRA. On 10th March 2016, the patient received BEXSERO .5 ml. On 10th March 2016, less than a day after receiving BEXSERO, the patient experienced shoulder pain and injection site pain. In March 2016, the patient experienced tingling of extremity. On an unknown date, the outcome of the shoulder pain and injection site pain were not recovered/not resolved and the outcome of the tingling of extremity was unknown. It was unknown if the reporter considered the shoulder pain, injection site pain and tingling of extremity to be related to BEXSERO. Additional details were as follows: The patient experienced deep left shoulder pain, painful to touch at injection site and tingling down left arm (less than a week after vaccination). The reporter was unable to provide patient''s date of birth.


Changed on 9/14/2018

VAERS ID: 629126 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:2016-03-10
Onset:2016-03-10
Submitted:2016-03-24
Entered:2016-03-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS PP148901A / UNK LA / UN
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site pain, Musculoskeletal pain, Paraesthesia

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016038974

Write-up: This case was reported by a physician via call center representative and described the occurrence of shoulder pain in a female patient who received BEXSERO (batch number PP-148901A, expiry date 30th September 2016). Concomitant products included MENACTRA. On 10th March 2016, the patient received BEXSERO .5 ml. On 10th March 2016, less than a day after receiving BEXSERO, the patient experienced shoulder pain and injection site pain. In March 2016, the patient experienced tingling of extremity. On an unknown date, the outcome of the shoulder pain and injection site pain were not recovered/not resolved and the outcome of the tingling of extremity was unknown. It was unknown if the reporter considered the shoulder pain, injection site pain and tingling of extremity to be related to BEXSERO. Additional details were as follows: The patient experienced deep left shoulder pain, painful to touch at injection site and tingling down left arm (less than a week after vaccination). The reporter was unable to provide patient''s date of birth.


Changed on 10/14/2018

VAERS ID: 629126 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:2016-03-10
Onset:2016-03-10
Submitted:2016-03-24
Entered:2016-03-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS PP148901A / UNK LA / UN
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site pain, Musculoskeletal pain, Paraesthesia

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016038974

Write-up: This case was reported by a physician via call center representative and described the occurrence of shoulder pain in a female patient who received BEXSERO (batch number PP-148901A, expiry date 30th September 2016). Concomitant products included MENACTRA. On 10th March 2016, the patient received BEXSERO .5 ml. On 10th March 2016, less than a day after receiving BEXSERO, the patient experienced shoulder pain and injection site pain. In March 2016, the patient experienced tingling of extremity. On an unknown date, the outcome of the shoulder pain and injection site pain were not recovered/not resolved and the outcome of the tingling of extremity was unknown. It was unknown if the reporter considered the shoulder pain, injection site pain and tingling of extremity to be related to BEXSERO. Additional details were as follows: The patient experienced deep left shoulder pain, painful to touch at injection site and tingling down left arm (less than a week after vaccination). The reporter was unable to provide patient''s date of birth.


Changed on 12/24/2020

VAERS ID: 629126 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:2016-03-10
Onset:2016-03-10
Submitted:2016-03-24
Entered:2016-03-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS PP148901A / UNK LA / UN
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site pain, Musculoskeletal pain, Paraesthesia

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016038974

Write-up: This case was reported by a physician via call center representative and described the occurrence of shoulder pain in a female patient who received BEXSERO (batch number PP-148901A, expiry date 30th September 2016). Concomitant products included MENACTRA. On 10th March 2016, the patient received BEXSERO .5 ml. On 10th March 2016, less than a day after receiving BEXSERO, the patient experienced shoulder pain and injection site pain. In March 2016, the patient experienced tingling of extremity. On an unknown date, the outcome of the shoulder pain and injection site pain were not recovered/not resolved and the outcome of the tingling of extremity was unknown. It was unknown if the reporter considered the shoulder pain, injection site pain and tingling of extremity to be related to BEXSERO. Additional details were as follows: The patient experienced deep left shoulder pain, painful to touch at injection site and tingling down left arm (less than a week after vaccination). The reporter was unable to provide patient''s date of birth.


Changed on 12/30/2020

VAERS ID: 629126 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:2016-03-10
Onset:2016-03-10
Submitted:2016-03-24
Entered:2016-03-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS PP148901A / UNK LA / UN
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site pain, Musculoskeletal pain, Paraesthesia

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016038974

Write-up: This case was reported by a physician via call center representative and described the occurrence of shoulder pain in a female patient who received BEXSERO (batch number PP-148901A, expiry date 30th September 2016). Concomitant products included MENACTRA. On 10th March 2016, the patient received BEXSERO .5 ml. On 10th March 2016, less than a day after receiving BEXSERO, the patient experienced shoulder pain and injection site pain. In March 2016, the patient experienced tingling of extremity. On an unknown date, the outcome of the shoulder pain and injection site pain were not recovered/not resolved and the outcome of the tingling of extremity was unknown. It was unknown if the reporter considered the shoulder pain, injection site pain and tingling of extremity to be related to BEXSERO. Additional details were as follows: The patient experienced deep left shoulder pain, painful to touch at injection site and tingling down left arm (less than a week after vaccination). The reporter was unable to provide patient''s date of birth.


Changed on 5/7/2021

VAERS ID: 629126 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:2016-03-10
Onset:2016-03-10
Submitted:2016-03-24
Entered:2016-03-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS PP148901A / UNK LA / UN
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site pain, Musculoskeletal pain, Paraesthesia

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016038974

Write-up: This case was reported by a physician via call center representative and described the occurrence of shoulder pain in a female patient who received BEXSERO (batch number PP-148901A, expiry date 30th September 2016). Concomitant products included MENACTRA. On 10th March 2016, the patient received BEXSERO .5 ml. On 10th March 2016, less than a day after receiving BEXSERO, the patient experienced shoulder pain and injection site pain. In March 2016, the patient experienced tingling of extremity. On an unknown date, the outcome of the shoulder pain and injection site pain were not recovered/not resolved and the outcome of the tingling of extremity was unknown. It was unknown if the reporter considered the shoulder pain, injection site pain and tingling of extremity to be related to BEXSERO. Additional details were as follows: The patient experienced deep left shoulder pain, painful to touch at injection site and tingling down left arm (less than a week after vaccination). The reporter was unable to provide patient''s date of birth.


Changed on 5/21/2021

VAERS ID: 629126 Before After
VAERS Form:1
Age:
Sex:Female
Location:Unknown
Vaccinated:2016-03-10
Onset:2016-03-10
Submitted:2016-03-24
Entered:2016-03-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS PP148901A / UNK LA / UN
MNQ: MENINGOCOCCAL CONJUGATE (MENACTRA) / SANOFI PASTEUR - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Injection site pain, Musculoskeletal pain, Paraesthesia

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': US2016038974

Write-up: This case was reported by a physician via call center representative and described the occurrence of shoulder pain in a female patient who received BEXSERO (batch number PP-148901A, expiry date 30th September 2016). Concomitant products included MENACTRA. On 10th March 2016, the patient received BEXSERO .5 ml. On 10th March 2016, less than a day after receiving BEXSERO, the patient experienced shoulder pain and injection site pain. In March 2016, the patient experienced tingling of extremity. On an unknown date, the outcome of the shoulder pain and injection site pain were not recovered/not resolved and the outcome of the tingling of extremity was unknown. It was unknown if the reporter considered the shoulder pain, injection site pain and tingling of extremity to be related to BEXSERO. Additional details were as follows: The patient experienced deep left shoulder pain, painful to touch at injection site and tingling down left arm (less than a week after vaccination). The reporter was unable to provide patient''s date of birth.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=629126&WAYBACKHISTORY=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166